Convalescent Plasma Reduces Hospitalizations for Outpatients with Recent COVID-19 Infection
In the setting of the public health catastrophe brought on by COVID with limited therapeutic interventions initially available, new and old therapies were evaluated to avert further death and disability. COVID-19 convalescent plasma (CCP) became one of the most common therapies early in the pandemic with more than 100,000 units distributed to hospitals every month just in the United States. However, limited data were available on the efficacy. Physician-scientists at Johns Hopkins noted that ...
Read More